Doctor profile · Federal record
Dr. Jane Winter, MD
Hematology & Oncology Physician (CMS: Hematology) · Hematology (Internal Medicine) Physician · Chicago, IL
- NPI 1306864160
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 49 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
675 N Saint Clair St, Galter 21-100
Chicago, IL 606115975
(312) 695-0990
fax (312) 695-1106 - Mailing address
-
680 N Lake Shore Dr, Suite 1000
Chicago, IL 606114546
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- May 26, 2020
- Year of graduation
- 1977 — 49 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036057716
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306864160. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
30,679
Distinct HCPCS
10
Medicare allowed
$1,009,779
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,830 | 30 | $47 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,950 | 29 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 4,400 | 15 | $52 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,920 | 34 | $44 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,601 | 16 | $28 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 1,248 | 16 | $28 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,221 | 25 | $5 | |
J9305 |
Injection, pemetrexed, not otherwise specified, 10 mg | 1,193 | 11 | $16 | |
J0461 |
Injection, atropine sulfate, 0.01 mg | 800 | 15 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 712 | 54 | $0 |
In context: peer comparison
Among 77 peers in this city , average services per provider: 870. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$6,534
Transactions
6
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $3,342.50 | |
| Genentech USA, Inc. | 3 | $3,122.59 | |
| AstraZeneca Pharmaceuticals LP | 2 | $68.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
195
Patients
56
Total drug cost
$222,977
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 106 | 44 | $1,829 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 27 | 0 | $198 |
| Allopurinol | Generic | 18 | 12 | $249 |
| Gabapentin | Generic | 18 | 0 | $293 |
| Brukinsa (Zanubrutinib) | Brand | 15 | 0 | $220,327 |
| Prednisone | Generic | 11 | 0 | $81 |
Hospital affiliations
Frequently asked questions
What is Dr. Jane Winter's medical specialty?
Dr. Jane Winter practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Jane Winter practice?
Dr. Jane Winter practices at 675 N Saint Clair St, Chicago, IL 606115975. Office phone: 3126950990.
What is Dr. Jane Winter's NPI?
Dr. Jane Winter's National Provider Identifier (NPI) is 1306864160, issued by NPPES.
Does Dr. Jane Winter accept Medicare assignment?
Yes. Dr. Jane Winter accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jane Winter commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.